GILTUSS HBP EX EXPECTORANT- giltuss hbp ex expectorant tablet 
Gil Pharmaceutical Corp

----------

Giltuss HBP EX
EXPECTORANT / EXPECTORANTE
Guaifenesin 600 mg

Drug Facts

Active ingredient Purpose (in each extended-release bi-layer tablet)

Guaifenesin, 600 mg....................................................................Expectorant

Uses

Warnings

Ask a doctor before use if you have

Stop use and ask a doctor if

Cough lasts more than than 7 days, comes back, or occurs with fever, rash, or persistent headache. These could be signs of serious illness.

If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children. In case of accidental overdose, get medical or professional help or contact a Poison Control Center right away (1-800-222-1222).

Directions

Other information

Inactive ingredients:carbomer homopolymer type B; hypromellose; magnesium stearate; microcrystalline cellulose, sodium starch  glycolate.

Questions or comments?

Call 1-787-848-9114, Monday–Friday 9AM-5PM EST. Call your doctor for medical advice in the event of side effects.

revised: 08/25

PRINCIPAL DISPLAY PANEL

GILTUSS HBP EX EXPECTORANT / EXPECTORANTE (Guaifenesin 600 mg) - NDC 58552-340-20 - 20 Tabs Bottle label

image description

GILTUSS HBP EX EXPECTORANT 
giltuss hbp ex expectorant tablet
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:58552-340
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
GUAIFENESIN (UNII: 495W7451VQ) (GUAIFENESIN - UNII:495W7451VQ) GUAIFENESIN600 mg
Inactive Ingredients
Ingredient NameStrength
CARBOMER HOMOPOLYMER TYPE B (ALLYL SUCROSE CROSSLINKED) (UNII: Z135WT9208)  
HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
SODIUM STARCH GLYCOLATE TYPE A (UNII: H8AV0SQX4D)  
Product Characteristics
ColorwhiteScoreno score
ShapeOVALSize16mm
FlavorImprint Code G
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:58552-340-201 in 1 CARTON10/07/2025
120 in 1 BOTTLE; Type 0: Not a Combination Product
2NDC:58552-340-071 in 1 CARTON10/07/2025
27 in 1 BLISTER PACK; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM01210/07/2025
Labeler - Gil Pharmaceutical Corp (176826592)
Establishment
NameAddressID/FEIBusiness Operations
Neeyaan, LLC118819217manufacture(58552-340)

Revised: 10/2025
Document Id: 40bac77b-aae7-a4ae-e063-6294a90ac55c
Set id: 31bd6356-27cf-4188-8fd5-9cd9392021ca
Version: 1
Effective Time: 20251009
 
Gil Pharmaceutical Corp